InnoCare Pharma Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-485.00
-706.00
-1,028.00
-23.00
-440.00
-2,438.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-20.00
-268.00
-87.00
144.00
-63.00
97.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-251.00
-604.00
-661.00
294.00
-157.00
12.00
Cash Flow from Investing Activities
1,059.00
599.00
-2,007.00
-2,180.00
-1,281.00
-50.00
Cash Flow from Financing Activities
-309.00
1.00
3,602.00
3,070.00
2,516.00
406.00
Net Cash Inflow / Outflow
517.00
24.00
1,096.00
1,128.00
794.00
389.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
18.00
28.00
162.00
-54.00
-282.00
20.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of InnoCare Pharma Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-485.009055099572
2738.14442927306
-3,223.00
-117.71%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-20.0439854273168
-1135.92614066265
1,115.00
98.24%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-251.323325362712
4552.50846025179
-4,803.00
-105.52%
Cash Flow from Investing Activities
1059.69169932939
-3469.87951101534
4,528.00
130.54%
Cash Flow from Financing Activities
-309.648333238558
-1265.3466880714
956.00
75.53%
Net Cash Inflow / Outflow
517.069247753296
-152.371397706972
669.00
439.35%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
18.3492070251739
30.3463411279783
-12.00
-39.53%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 58.40% vs 8.66% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-251.32
-604.19
58.40%






